Company Analysis

Champions Oncology, Inc. (CSBR)

Nasdaq: CSBR · Biological Products, (No Diagnostic Substances) · Baltimore, MD · filing with the SEC since 1995
Grade5.9
◀ Past 6.9● Present 6.6▶ Future 4.1
1 est.

Income statement, as filed

In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in April.
Income statement, by fiscal year, newest first
Fiscal yearFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingApr 30, 2026Apr 30, 2025Apr 30, 2024Apr 30, 2023Apr 30, 2022Apr 30, 2021Apr 30, 2020Apr 30, 2019Apr 30, 2018Apr 30, 2017
Report filedJul 27, 2026Jul 23, 2025Jul 19, 2024Jul 24, 2023Jul 22, 2022Jul 26, 2021Jul 28, 2020Jul 29, 2019Jul 30, 2018Jul 28, 2017
Revenue59,42556,94450,15553,87049,10941,04032,12327,06720,24115,411
Cost of revenue30,90028,38929,40129,53223,63221,44617,000···
Research and development9,0846,8259,54411,5459,3747,1965,8534,7984,4014,293
Sales and marketing9,3187,5457,0647,0026,3795,5204,2423,0562,5703,261
General and administrative11,1529,33911,06710,2409,1176,5126,6144,6784,0714,963
Total operating expenses······33,92626,79721,59522,220
Total costs and expenses60,56552,39157,51159,12648,50240,67434,044···
Operating income-1,1404,553-7,356-5,256607366-1,921r270-1,354-6,809
Other income (expense), net2117348-11-2471-42-39-89-56
Total non-operating income (expense)·······-39-89-56
Income before income taxes-9294,626-7,308-5,267583437-1,963r231-1,443-6,865
Income tax expense246-75-326835751301033319
Net income including non-controlling interests-1,1754,701········
Net income-1,1754,701-7,276-5,335548362-2,093r128-1,476-6,884r
Earnings per share, basic-0.080.34-0.54-0.390.040.03-0.18r0.01-0.13·
Earnings per share, diluted-0.080.33-0.54-0.390.040.02-0.18r0.01-0.13·
Earnings per share, basic and diluted········-0.13-0.64
Weighted average shares, basic13,832,38513,659,78613,547,60413,541,55913,197,17013,138,99511,843,46311,340,18410,991,105·
Weighted average shares, diluted13,832,38514,266,78113,547,60413,541,55914,159,79914,573,56111,843,46314,096,11710,991,105·
Weighted average shares, basic and diluted·····13,138,99511,843,46311,340,18410,991,10510,684,395
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-12 reverse split.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:SalesRevenueServicesNet
Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfGoodsAndServicesSold
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
Sales and marketing the cost of finding and serving customersus-gaap:SellingAndMarketingExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Total costs and expenses every operating cost, the cost of revenue includedus-gaap:OperatingCostsAndExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
SI Assistanton CSBR · research, not advice